Higher than expected sales of specialty and improving traction in Ilumya were key positives; ‘Buy’ maintained with target price of Rs 525
from The Financial Express https://ift.tt/2AnzWef
Sunday, 31 May 2020
Sun Pharma rating: Buy — Quarter results were in line with estimates
Subscribe via email
About Unknown
SoraTemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of SoraTemplates is to provide the best quality blogger templates.
Newer Article
New working world: How a virus killed job descriptions
Older Article
Jindal rating: Maintain ‘outperform’ with an unchanged target price of Rs 175
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment